114
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials

, , , , , , & show all
Pages 1723-1731 | Published online: 24 Jul 2017

References

  • Global Burden of Disease Study 2013 CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet2015386999574380026063472
  • DagenaisSCaroJHaldemanSA systematic review of low back pain cost of illness studies in the United States and internationallySpine J20088182018164449
  • NakamuraMNishiwakiYUshidaTToyamaYPrevalence and characteristics of chronic musculoskeletal pain in JapanJ Orthop Sci201116442443221678085
  • SukaMYoshidaKLow back pain deprives the Japanese adult population of their quality of life: a questionnaire survey at five healthcare facilities in JapanEnviron Health Prev Med200813210911519568889
  • HoyDBainCWilliamsGA systematic review of the global prevalence of low back painArthritis Rheum20126462028203722231424
  • WebsterLRMarkmanJMedical management of chronic low back pain: efficacy and outcomesNeuromodulation201417suppl 2182325395113
  • ClauwDJDiagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s)Best Pract Res Clin Rheumatol201529161926266995
  • PhillipsKClauwDJCentral pain mechanisms in chronic pain states – maybe it is all in their headBest Pract Res Clin Rheumatol201125214115422094191
  • AiraksinenOBroxJICedraschiCChapter 4. European guidelines for the management of chronic nonspecific low back painEur Spine J200615suppl 2S192S30016550448
  • ChouRQaseemASnowVClinical Efficacy Assessment Subcommittee of the American College of PhysiciansAmerican College of PhysiciansAmerican Pain Society Low Back Pain Guidelines PanelDiagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain SocietyAnn Intern Med2007147747849117909209
  • BymasterFPBeedleEEFindlayJDuloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptakeBioorg Med Chem Lett200313244477448014643350
  • KarpaKDCavanaughJELakoskiJMDuloxetine pharmacology: profile of a dual monoamine modulatorCNS Drug Rev20028436137612481192
  • SmithHSSmithEJSmithBRDuloxetine in the management of chronic musculoskeletal painTher Clin Risk Manag2012826727722767991
  • KonnoSOdaNOchiaiTAlevLA randomized, double-blind, placebo-controlled phase III trial of duloxetine monotherapy in Japanese patients with chronic low back painSpine (Phila Pa 1976)201641221709171727831985
  • SkljarevskiVDesaiahDLiu-SeifertHEfficacy and safety of duloxetine in patients with chronic low back painSpine (Phila Pa 1976)20103513E578E58520461028
  • SkljarevskiVOssannaMLiu-SeifertHA double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back painEur J Neurol20091691041104819469829
  • SkljarevskiVZhangSDesaiahDDuloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trialJ Pain201011121282129020472510
  • FarasynAMeeusenRThe influence of non-specific low back pain on pressure pain thresholds and disabilityEur J Pain20059437538115979017
  • GiesbrechtRJBattieMCA comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without painPhys Ther200585101085109216180957
  • GieseckeTGracelyRHGrantMAEvidence of augmented central pain processing in idiopathic chronic low back painArthritis Rheum200450261362314872506
  • ImamuraMChenJMatsubayashiSRChanges in pressure pain threshold in patients with chronic nonspecific low back painSpine (Phila Pa 1976)201338242098210724026153
  • PutaCSchulzBSchoelerSEnhanced sensitivity to punctate painful stimuli in female patients with chronic low back painBMC Neurol2012129822998460
  • StaudREvidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgiaCurr Rheumatol Rep201113651352021833699
  • HartvigsenJNatvigBFerreiraMIs it all about a pain in the back?Best Pract Res Clin Rheumatol201327561362324315143
  • BrummettCMBakshiRRGoeslingJPreliminary validation of the Michigan Body Map (MBM)Pain201615761205121226835782
  • KellerSBannCMDoddSLScheinJMendozaTRCleelandCSValidity of the brief pain inventory for use in documenting the outcomes of patients with noncancer painClin J Pain200420530931815322437
  • FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
  • RobinsonMEBrownJLGeorgeSZMultidimensional success criteria and expectations for treatment of chronic pain: the patient perspectivePain Med20056533634516266354
  • FarrarJTPritchettYLRobinsonMPrakashAChappellAThe clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disordersJ Pain201011210911819665938
  • WangFRubergSJGaynorPJHeinlothANArnoldLMEarly improvement in pain predicts pain response at endpoint in patients with fibromyalgiaJ Pain201112101088109421763211
  • JensenMPHsuPHVanhoveGFEarly pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgiaPain Med20121381059106622757655
  • WilliamsonODSchroerMRuffDDOnset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trialsClin Ther201436454455124650448
  • KalsoESimpsonKHSlappendelRDejonckheereJRicharzUPredicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphineBMC Med200753918154644
  • PatelKVGuralnikJMDansieEJTurkDCPrevalence and impact of pain among older adults in the United States: findings from the 2011 National Health and Aging Trends StudyPain2013154122649265724287107
  • Cymbalta® (duloxetine hydrochloride) [prescribing information]Indianapolis, IN, USAEli Lilly and Company2016 Available from: http://pi.lilly.com/us/cymbalta-pi.pdfAccessed February 2, 2017